Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1102.6000 11.70 (1.07%)
NSE Sep 25, 2025 13:01 PM
Volume: 841.4K
 

1102.60
1.07%
Geojit BNP Paribas
Though we maintain our BUY rating on the stock, given strong US sales, near term Sandoz deal closure and new product launches, we reduce the FY21E adj. EPS target multiple to 9x (vs 12x earlier) due to recent...
Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended